Tirzepatide represents a groundbreaking therapeutic agent for individuals battling type 2 diabetes. As a dual stimulator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://violacqoj282667.bloginwi.com/74314030/tirzepatide-a-new-frontier-in-diabetes-treatment